PCM1 and schizophrenia: A replication study in the northern Swedish population

9Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Previous studies implicated centrosomal dysfunction as a source of various neuropsychiatric disorders, including schizophrenia (SZ). Two recent reports [Gurling et al., 2006; Datta et al., 2008. Mol Psychiatry] described an association between polymorphisms in the PCM1 gene and SZ in a UK/Scottish population. In this study, we aimed to replicate these findings in a Northern Swedish association sample of 486 research subjects with SZ and 512 unrelated control individuals. We genotyped 12 previously described SNPmarkers and carried out haplotype analyses using the same multi-marker haplotypes previously reported. Though we could not replicate the association with SNPs rs445422 and rs208747, we did observe a significant protective association with intronic SNP rs13276297. Furthermore, we performed a meta-analysis comprising 1,794 SZ patients and 1,553 controls, which confirmed the previously reported association with rs445422 and rs208747. These data provide further evidence that PCM1 - though certainly not a major risk factor in the Northern Swedish population - cannot be ruled out as a contributor to SZ risk and/or protection, and deserves further replication in larger populations to elucidate its role in disease etiology. © 2010 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Moens, L. N., Ceulemans, S., Alaerts, M., Van Den Bossche, M. J. A., Lenaerts, A. S., De Zutter, S., … Del-Favero, J. (2010). PCM1 and schizophrenia: A replication study in the northern Swedish population. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, 153(6), 1240–1243. https://doi.org/10.1002/ajmg.b.31088

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free